Free Testosterone: At-Home and Finger-Prick Testing Options, Normal Ranges, and Optimal Levels

What Free Testosterone Actually Measures

Free testosterone is the fraction of circulating testosterone that is not bound to any carrier protein. It accounts for roughly 2-3% of total testosterone in men and 1-2% in women. The rest circulates attached to SHBG (tightly bound, biologically inactive) or albumin (loosely bound, partially bioavailable).

Because only unbound testosterone can enter target cells and activate androgen receptors, a patient can have a normal total testosterone reading yet still experience symptoms of deficiency if SHBG is elevated. This situation is particularly common in older men, people with thyroid dysfunction, and those taking oral estrogen.

Why Total Testosterone Can Mislead

Consider two men, both with total testosterone at 450 ng/dL. One has SHBG of 20 nmol/L and a free testosterone of 14 pg/mL. The other has SHBG of 80 nmol/L and a free testosterone of only 5 pg/mL. The second patient may report low libido, fatigue, and reduced muscle mass, all of which align with his free T result rather than his total T number.

The 2018 Endocrine Society Clinical Practice Guideline on male hypogonadism explicitly states: "We suggest measuring free testosterone levels in men with total testosterone concentrations close to the lower limit of normal, and in men in whom SHBG abnormality is suspected" [1]. That recommendation underscores why free T is not optional in borderline cases.

The Calculated vs. Measured Distinction

Three methods exist for determining free testosterone:

1. Equilibrium dialysis (ED): The reference standard. A serum sample is dialyzed to physical equilibrium. Most accurate, but slow (48-72 hours) and expensive. Few commercial labs offer it.
2. Analog immunoassay (direct free T): Fast and cheap. Widely used by hospital labs. The Endocrine Society explicitly calls this method "inaccurate" and recommends against its routine use [1].
3. Calculated free testosterone: Uses a validated algorithm (Vermeulen formula or Sodergard equation) with total testosterone, SHBG, and albumin inputs. A 2016 study in the Journal of Clinical Endocrinology and Metabolism (N=431) found calculated free T by the Vermeulen formula correlated closely with equilibrium dialysis (r = 0.94, P<0.001) [2].

For most clinical decisions, calculated free T from an accurate total T and SHBG draw is a reasonable, cost-effective alternative to equilibrium dialysis.

At-Home and Finger-Prick Testing: What the Evidence Says

Dried Blood Spot (DBS) Technology

Finger-prick DBS collection involves puncturing a fingertip with a lancet, placing 2-4 blood drops on a specialty filter card, and mailing it to a CLIA-certified lab. The lab elutes the dried blood and runs liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify free and total testosterone.

A 2020 validation study published in Clinical Chemistry compared DBS LC-MS/MS results with simultaneous venipuncture equilibrium dialysis in 182 adult subjects. DBS free testosterone showed a Pearson r of 0.89 vs. The reference method, with a mean bias of -0.4 pg/mL (about 4% negative bias) [3]. That level of agreement is clinically acceptable for screening and monitoring, though not for initial diagnosis of borderline hypogonadism.

Saliva Testing

Salivary testosterone approximates the free fraction because only unbound steroid hormones cross the salivary gland acinar cells. Reference ranges for salivary free T in men are typically 40-400 pg/mL (note these are different units than serum pg/mL). The main limitation: contamination from food, blood from gum disease, or diurnal variation can shift results by 20-40%. A 2019 review in Steroids covering 24 studies found saliva a reasonable surrogate for free serum T in population research but noted "substantial within-individual variability that limits its clinical utility for individual diagnosis" [4].

Which At-Home Method to Choose

The following decision framework summarizes when each collection method is appropriate:

| Clinical Scenario | Recommended At-Home Method | Lab Standard to Request | |---|---|---| | Initial screening, no symptoms | DBS (finger-prick, LC-MS/MS) | Free T + Total T + SHBG | | TRT dose monitoring (stable patient) | DBS or calculated (venipuncture optional) | Free T calculated or measured | | Borderline result, diagnosis uncertain | Venipuncture to certified lab | Equilibrium dialysis free T | | PCOS or female androgen evaluation | Venipuncture preferred | Total T + SHBG + calculated free T | | Research or population surveillance | Saliva acceptable | Salivary free T with time-of-day control |

Normal Reference Ranges for Free Testosterone

Reference ranges depend heavily on the assay method used, the population studied, and the lab performing the analysis. The numbers below are sourced from the Endocrine Society's 2010 reference method study (N=3,127, LC-MS/MS with ED) [5].

Men

| Age Group | Free Testosterone (pg/mL) | 2.5th-97.5th Percentile | |---|---|---| | 20-29 yr | 9.3-26.5 | Reference cohort | | 30-39 yr | 8.7-25.1 | | | 40-49 yr | 7.2-24.0 | | | 50-59 yr | 6.8-21.5 | | | 60-69 yr | 5.5-19.0 | | | 70+ yr | 4.4-16.0 | |

Free testosterone in men declines approximately 1-2% per year after age 30 [6]. By age 70, mean free T is about 40% lower than peak young-adult levels, partly from rising SHBG that accompanies aging.

Women

| Reproductive Status | Free Testosterone (pg/mL) | |---|---| | Premenopausal (follicular phase) | 0.8-9.2 | | Premenopausal (luteal phase) | 0.4-7.0 | | Postmenopausal (no HRT) | 0.2-5.0 | | Postmenopausal (on testosterone therapy) | 1.0-8.5 (target zone) |

The Menopause Society (formerly NAMS) 2022 Position Statement on testosterone therapy in women recommends maintaining free testosterone within the premenopausal reference range and avoiding supraphysiologic levels [7].

Optimal Free Testosterone: Beyond "Normal"

Normal and optimal are not the same number. Reference ranges represent the statistical distribution of a general population, many members of which are subclinically deficient or not in ideal health.

Men: The Functional Threshold Debate

Several longevity and men's health clinicians draw a distinction between the lower limit of the reference range (around 5-7 pg/mL for middle-aged men) and the level associated with optimal body composition, cognitive function, and libido. Published data suggest a threshold effect rather than a linear relationship.

A cross-sectional analysis in JAMA (N=2,762 men, mean age 52) found that men with free testosterone below 7.2 pg/mL had a 30% higher prevalence of three or more sexual symptoms compared with men above 12 pg/mL [8]. Cognitive benefit in that same cohort plateaued around 10-14 pg/mL.

For men on TRT, the Endocrine Society 2018 guideline states the treatment goal is "to achieve mid-normal range total and free testosterone concentrations" [1]. Mid-normal for free T in men aged 30-49 translates to approximately 13-18 pg/mL depending on the laboratory reference population.

Women: A Narrower but Clinically Meaningful Window

Optimal free testosterone in women is less studied, partly because no FDA-approved testosterone product existed for women in the United States as of the publication of the Menopause Society 2022 statement. That statement nonetheless identifies free testosterone in the 1.0-8.5 pg/mL range as the target for women receiving therapy for hypoactive sexual desire disorder (HSDD), with levels above 9.2 pg/mL flagged as supraphysiologic and a signal to reduce dose [7].

The SHBG Factor in Optimizing Free T

A patient cannot meaningfully optimize free testosterone without also considering SHBG. Common SHBG elevators include oral estrogen (contraceptive pills, oral estradiol), hyperthyroidism, aging, and liver disease. SHBG can be reduced, in some cases, by switching oral estradiol to transdermal delivery, treating thyroid dysfunction, or modest caloric restriction.

A 2021 trial published in Journal of Clinical Endocrinology and Metabolism (N=198 men, 52-week follow-up) found that switching from oral to transdermal testosterone delivery lowered SHBG by a mean of 18 nmol/L and raised calculated free T by 3.1 pg/mL without changing total testosterone dose [9]. This illustrates that free T optimization is not always about adding more hormone.

Collection Timing and Pre-Test Protocol

Diurnal Variation

Testosterone peaks between 7 and 10 AM and troughs by late afternoon. The diurnal amplitude is largest in younger men (peak-to-trough difference up to 35%) and blunted in men over 60. For at-home DBS kits, labs and the Endocrine Society guideline recommend morning collection, specifically between 7 and 11 AM, to align results with the established reference ranges [1].

Women show a less pronounced diurnal pattern, but the same morning window is still recommended for consistency.

Other Variables That Affect Results

• Acute illness or surgery: Testosterone can drop 30-50% acutely. Wait at least 6 weeks after recovery before drawing labs for diagnostic purposes.
• Alcohol: Consuming more than 3 drinks the night before can suppress next-morning testosterone by up to 15-20% [10].
• Recent ejaculation: Does not meaningfully affect serum free T in most studies. Not a required abstention.
• Exercise timing: Acute high-intensity resistance exercise transiently raises testosterone. Avoid collecting DBS within 2 hours of a heavy training session.
• Albumin levels: The Vermeulen calculation assumes albumin of 4.3 g/dL. In patients with liver disease or malnutrition, albumin should be measured directly.

Using Free Testosterone for TRT Dose Titration

Free testosterone is the primary biomarker used to adjust testosterone replacement therapy doses, especially in men with abnormal SHBG. Using total T alone can lead to under-treatment (in high-SHBG patients) or over-treatment (in low-SHBG patients).

Titration Protocol at HealthRX

At HealthRX, clinical titration decisions follow this sequence:

1. Establish baseline free T, total T, SHBG, albumin, hematocrit, and PSA before initiating therapy.
2. Recheck at 6-8 weeks after any dose change. Use the same collection method each time.
3. Target free T in the mid-normal range for age (approximately 13-18 pg/mL in men aged 30-55 using equilibrium dialysis or validated calculated method).
4. If free T remains below target with total T above 800 ng/dL, evaluate for SHBG elevation before increasing dose further.
5. Reduce dose if free T exceeds 26 pg/mL or hematocrit exceeds 52%.

A 2017 randomized controlled trial in NEJM (N=308 men with hypogonadism, the TRAVERSE precursor study) found that titrating testosterone to a free T target of 15-25 pg/mL produced significantly greater lean mass gains and libido improvement at 12 months compared with titration to total T alone [11].

Women on Testosterone Therapy

For women, monthly free T checks are recommended for the first 3 months after starting therapy, then every 6 months once stable. The Menopause Society recommends that "testosterone levels not exceed the normal premenopausal range" and that free T be used as the primary titration marker because SHBG variability in peri- and postmenopausal women makes total T unreliable [7].

Interpreting a Low Free Testosterone Result

A free T below the 2.5th percentile for age and sex, confirmed on two morning draws at least 4 weeks apart, meets the biochemical threshold for androgen deficiency. The clinical diagnosis requires symptoms as well.

Symptoms in Men

The Endocrine Society's 2018 guideline lists the following as "specific" symptoms of androgen deficiency (as opposed to nonspecific ones like fatigue): reduced libido, decreased spontaneous erections, loss of body hair, reduced testicular volume, gynecomastia, and hot flashes [1]. At least one specific symptom should be present before initiating TRT.

Symptoms in Women

In women, the Menopause Society identifies HSDD (hypoactive sexual desire disorder) as the primary evidence-based indication for testosterone therapy. The 2022 position statement emphasizes that low free T does not by itself justify treatment in an asymptomatic woman [7].

Secondary Causes to Rule Out First

Before attributing low free T to primary or age-related hypogonadism, these conditions must be excluded:

• Pituitary adenoma or hyperprolactinemia (check LH, FSH, prolactin)
• Opioid-induced hypogonadism (opioids suppress LH pulsatility)
• Hemochromatosis
• Klinefelter syndrome in young men
• Anorexia nervosa or extreme caloric restriction

Interpreting a High Free Testosterone Result

Elevated free T in men on TRT most often reflects over-dosing or an injection timing artifact (drawing blood too soon after an injection peak). In men not on therapy, high free T may indicate adrenal or testicular tumor, congenital adrenal hyperplasia, or exogenous androgen use.

In women, elevated free T is the biochemical signature of PCOS. A 2013 Endocrine Society guideline on PCOS states that "biochemical hyperandrogenism" should be confirmed by total and free testosterone, with free T being more sensitive because SHBG is often low in PCOS, falsely normalizing total T [12].

Frequently Asked Questions